Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gore

Showing results (31-40 of 306) with videos related to

Pageof 31
Sort By:
Seminars in Hematology|January 9, 2008
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromesElizabeth A Griffiths, Steven D Gore
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approachAmer M Zeidan, Steven D Gore
The Journal of Burn Care & Rehabilitation|January 1, 1995
Evaluation of calcium alginate for skin graft donor sitesD Bettinger, D Gore, Y Humphries
Seminars in Oncology|March 12, 1999
Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemiaW J Edenfield, S D Gore
Endocrinology|June 1, 1984
Alteration of transmembrane sodium and potassium gradients inhibits the action of luteinizing hormone in the luteal cellS D Gore, H R Behrman
Expert Opinion on Investigational Drugs|November 28, 2000
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitorsS D Gore, M A Carducci
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for the treatment of myelodysplastic syndromePhilip J Nivatpumin, Steven D Gore
Oncology (Williston Park, N.Y.)|July 2, 2011
Myelodysplastic syndromes: where do we go from here?Hetty E Carraway, Steven D Gore
Leukemia & Lymphoma|February 2, 2022
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesisRory M Shallis, Steven D Gore
Nature Reviews. Drug Discovery|November 23, 2006
DecitabineSteven D Gore, Carole Jones, Peter Kirkpatrick
Pageof 31

Showing results (31-40 of 306) with videos related to

Sort By:
Pageof 31
Seminars in Hematology|January 9, 2008
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromesElizabeth A Griffiths, Steven D Gore
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2014
New strategies in acute promyelocytic leukemia: moving to an entirely oral, chemotherapy-free upfront management approachAmer M Zeidan, Steven D Gore
The Journal of Burn Care & Rehabilitation|January 1, 1995
Evaluation of calcium alginate for skin graft donor sitesD Bettinger, D Gore, Y Humphries
Seminars in Oncology|March 12, 1999
Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemiaW J Edenfield, S D Gore
Endocrinology|June 1, 1984
Alteration of transmembrane sodium and potassium gradients inhibits the action of luteinizing hormone in the luteal cellS D Gore, H R Behrman
Expert Opinion on Investigational Drugs|November 28, 2000
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitorsS D Gore, M A Carducci
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for the treatment of myelodysplastic syndromePhilip J Nivatpumin, Steven D Gore
Oncology (Williston Park, N.Y.)|July 2, 2011
Myelodysplastic syndromes: where do we go from here?Hetty E Carraway, Steven D Gore
Leukemia & Lymphoma|February 2, 2022
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesisRory M Shallis, Steven D Gore
Nature Reviews. Drug Discovery|November 23, 2006
DecitabineSteven D Gore, Carole Jones, Peter Kirkpatrick
Pageof 31